GE Sells BioPharma Business to Danaher for $21.4 Billion, an Industrial Info Market Brief
GE Sells BioPharma Business to Danaher for $21.4 Billion, an Industrial Info Market Brief
Attachment: GE-biobiz 0319
BioPharma generates more than $3 billion in annual sales for GE
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- GE Healthcare Reveals New Plants for Ireland
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- One of NextEra's $59 Billion in Renewable-Generation Projects Breaks Ground
- U.S. Wind Turbine-Manufacturing Projects Gain Ground
- Ørsted Completes U.S. Offshore Windfarm, Divests Stake in Onshore Wind Asse...